Literature DB >> 10668435

Neuroprotective properties of nitric oxide.

C C Chiueh1.   

Abstract

The discoveries of physiological roles of nitric oxide (.NO) as the mediator of endothelium-derived relaxing factor (EDRF) action and the activator of guanylyl cyclase to increase cyclic guanosine monophosphate (cGMP), which lead to vasorelaxation in the cardiovascular system, have been awarded with the 1998 Nobel Prize of Medicine. The present review discusses putative beneficial effects of .NO in the central nervous system (CNS). In addition to its prominent roles of the regulation of cerebral blood flow and the modulation of cell to cell communication in the brain, recent in vitro and in vivo results indicated that .NO is a potent antioxidative agent. .NO terminates oxidant stress in the brain by (i) suppressing iron-induced generation of hydroxyl radicals (.OH) via the Fenton reaction, (ii) interrupting the chain reaction of lipid peroxidation, (iii) augmenting the antioxidative potency of reduced glutathione (GSH) and (iv) inhibiting cysteine proteases. It is apparent that .NO--a relative long half-life nitrogen-centered weak radical--scavenges those short-lived, highly reactive free radicals such as superoxide anion (O2.-), .OH, peroxyl lipid radicals (LOO.) and thiyl radicals (i.e., GS.), yielding reactive nitrogen species including nitrites, nitrates, S-nitrosoglutathione (GSNO) and peroxynitrite (ONOO-). GSNO is 100-fold more potent than GSH; it completely inhibits the weak peroxidative effect of ONOO-. Moreover, CO2 and .NO neutralize prooxidative effects of ONOO-. CO2 prevents protein oxidation but not 3-nitrotyrosine formation caused by ONOO-. Finally, neuroprotective effects of GSNO and .NO have been demonstrated in brain preparations in vivo. These novel neuroprotective properties of .NO and GSNO may have their physiological significance, since oxidative stress depletes GSH while increasing GS. and .NO formation in astroglial and endothelial cells, resulting in the generation of a more potent antioxidant GSNO and providing additional neuro-protection at microM concentrations. This putative GSNO pathway (GSH-->GS.-->GSNO-->.NO + GSSG-->GSH) may be an important part of endogenous antioxidative defense system, which could protect neurons and other brain cells against oxidative stress caused by oxidants, iron complexes, proteases and cytokines. In conclusion, .NO is a potent antioxidant against oxidative damage caused by reactive oxygen species, which are generated by Fenton reaction or other mechanisms in the brain via redox cycling of iron complexes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668435     DOI: 10.1111/j.1749-6632.1999.tb08007.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  38 in total

1.  S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.

Authors:  Je-Seong Won; Balasubramaniam Annamalai; Seungho Choi; Inderjit Singh; Avtar K Singh
Journal:  Brain Res       Date:  2015-08-10       Impact factor: 3.252

2.  Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals.

Authors:  C C Chiueh; T Andoh; A R Lai; E Lai; G Krishna
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

3.  The P2X7-Egr pathway regulates nucleotide-dependent inflammatory gene expression in microglia.

Authors:  S A Friedle; V M Brautigam; M Nikodemova; M L Wright; J J Watters
Journal:  Glia       Date:  2010-09-27       Impact factor: 7.452

4.  Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation.

Authors:  Balasubramaniam Annamalai; Je-Seong Won; Seungho Choi; Inderjit Singh; Avtar K Singh
Journal:  Biochem Biophys Res Commun       Date:  2015-01-29       Impact factor: 3.575

Review 5.  Neurorestorative treatment of stroke: cell and pharmacological approaches.

Authors:  Jieli Chen; Michael Chopp
Journal:  NeuroRx       Date:  2006-10

6.  Protective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion.

Authors:  Je-Seong Won; Jinsu Kim; Balasubramaniam Annamalai; Anandakumar Shunmugavel; Inderjit Singh; Avtar K Singh
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 7.  Free radicals: properties, sources, targets, and their implication in various diseases.

Authors:  Alugoju Phaniendra; Dinesh Babu Jestadi; Latha Periyasamy
Journal:  Indian J Clin Biochem       Date:  2014-07-15

8.  Vanadyl sulfate administration protects the streptozotocin-induced oxidative damage to brain tissue in rats.

Authors:  Refiye Yanardag; Sevim Tunali
Journal:  Mol Cell Biochem       Date:  2006-03-11       Impact factor: 3.396

9.  Neuroprotective effect of inhaled nitric oxide on excitotoxic-induced brain damage in neonatal rat.

Authors:  Julien Pansiot; Gauthier Loron; Paul Olivier; Romain Fontaine; Christiane Charriaut-Marlangue; Jean-Christophe Mercier; Pierre Gressens; Olivier Baud
Journal:  PLoS One       Date:  2010-06-01       Impact factor: 3.240

Review 10.  Posttraumatic epilepsy: hemorrhage, free radicals and the molecular regulation of glutamate.

Authors:  L J Willmore; Yuto Ueda
Journal:  Neurochem Res       Date:  2008-09-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.